Rep. Joe Wilson

Maddy summaryThis bill modifies the $800 de minimis exemption for small shipments entering the U.S. duty-free. It excludes goods from nonmarket economy countries and nations on the U.S. trade "priority watchlist" from this exemption. Importers must submit detailed documentation (including origin, value, shipper details, and classification) to U.S. Customs within 180 days of enactment. Providing false information could result in $5,000 civil penalties per violation. The changes apply to shipments entered on or after 180 days after the bill’s enactment.

Maddy summaryHR 4034 would add cranial prostheses (such as medical wigs) to Medicare's list of covered durable medical equipment. It requires a dermatologist, oncologist, or attending physician to certify in writing that the prosthesis is medically necessary as part of rehabilitative treatment. This change directly affects Medicare beneficiaries experiencing hair loss due to medical conditions like cancer treatment who need these prostheses for health reasons. The bill does not cover cosmetic wigs but specifically targets medically necessary cranial prostheses under existing Medicare coverage rules.

Maddy summaryThe Leveling the Playing Field 2.0 Act (HR 3882) updates U.S. trade law to better address international trade practices that disadvantage American businesses. It establishes special rules for handling multiple investigations of the same merchandise (called "successive investigations"), requiring the Commerce Department to consider previous injury determinations when making new findings. The bill also creates mechanisms to address market distortions from foreign government subsidies, including currency undervaluation, and strengthens procedures to prevent duty evasion through certification requirements for importers. These changes primarily affect foreign exporters of goods subject to U.S. antidumping and countervailing duty investigations, as well as U.S. importers of those goods.

Maddy summaryHR 3611, the Kazakhstan Permanent Normal Trade Relations Act of 2023, makes Kazakhstan's existing "normal trade relations" (NTR) status permanent by removing the need for annual U.S. presidential reviews under the Trade Act of 1974. This bill directly affects U.S. trade policy with Kazakhstan, ending the requirement for the President to annually determine whether Kazakhstan meets emigration freedom standards (which it has satisfied since 1997). The key provision allows the President to formally extend permanent NTR treatment to Kazakhstan's products, eliminating the current annual review process. Once enacted, Kazakhstan would automatically receive the same most-favored-nation tariff rates as other NTR countries, streamlining trade without further congressional action.

Maddy summaryThis bill prohibits federal funding for gender transition procedures - including hormone therapy, puberty blockers, and surgeries like genital reassignment - across all federal programs and health plans. It exempts procedures for medical conditions (such as disorders of sex development) and treatment of complications arising from such procedures. The bill also blocks Affordable Care Act premium tax credits and cost-sharing reductions for health plans covering these services, though individuals may purchase separate non-federal-funded coverage. State and private insurers can still offer such coverage using their own funds, but federal subsidies cannot be applied to it.

Maddy summaryHR 3095, the "Address Iran’s Malign Posture Act," expands U.S. sanctions to target foreign entities providing financial services, material support, or acting on behalf of Iran’s Revolutionary Guard Corps or designated terrorist groups. It requires the President to block all U.S. financial transactions with these entities and mandates that any nuclear agreement with Iran must be approved by a two-thirds vote in the Senate as a treaty. The bill also sets a 2025 sunset date for these sanctions provisions and related waivers. This directly affects foreign banks, businesses, and individuals engaging in transactions with Iran’s military or terror-linked entities.

Maddy summaryThe International Nuclear Energy Act of 2023 establishes a White House office to coordinate U.S. international nuclear energy policy and creates a Nuclear Exports Working Group to develop a 10-year strategy for promoting U.S. nuclear exports. It provides $50 million annually for five years to assist "embarking civil nuclear nations" (countries developing nuclear programs) with technical capacity building, financing, and regulatory framework development for civil nuclear energy projects. The bill also requires a biennial conference on nuclear safety, security, and sustainability, and includes provisions to support the development and export of U.S. small modular reactor technology. It aims to strengthen U.S. competitiveness in the global nuclear energy market while promoting nuclear safety standards and nonproliferation. The legislation requires coordination across multiple federal agencies to support U.S. nuclear energy exports to partner nations.

Maddy summaryThis bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.

Maddy summaryThis bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.

Maddy summaryThis bill repeals specific provisions from the Affordable Care Act and its 2010 amendment that restricted certain physician referrals to hospitals under Medicare. It directly affects hospitals and physicians who previously faced limitations on referring Medicare patients to facilities they owned or had financial ties with. The key mechanism restores the original rules that allowed such referrals without the prior restrictions, effectively undoing the 2010 changes. This is a procedural change to existing law, not a new policy.